<?xml version="1.0" encoding="UTF-8"?>
<ref id="B40-viruses-12-00838">
 <label>40.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Neogi</surname>
    <given-names>U.</given-names>
   </name>
   <name>
    <surname>Singh</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Aralaguppe</surname>
    <given-names>S.G.</given-names>
   </name>
   <name>
    <surname>Rogers</surname>
    <given-names>L.C.</given-names>
   </name>
   <name>
    <surname>Njenda</surname>
    <given-names>D.T.</given-names>
   </name>
   <name>
    <surname>Sarafianos</surname>
    <given-names>S.G.</given-names>
   </name>
   <name>
    <surname>Hejdeman</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>SÃ¶nnerborg</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Singh</surname>
    <given-names>K.</given-names>
   </name>
  </person-group>
  <article-title>Ex vivo antiretroviral potency of newer integrase strand transfer inhibitors cabotegravir and bictegravir in HIV-1 non-B subtypes</article-title>
  <source>AIDS</source>
  <year>2017</year>
  <volume>32</volume>
  <fpage>469</fpage>
  <lpage>476</lpage>
  <pub-id pub-id-type="doi">10.1097/QAD.0000000000001726</pub-id>
  <?supplied-pmid 29239896?>
  <pub-id pub-id-type="pmid">29239896</pub-id>
 </element-citation>
</ref>
